Discover your unique NeuroEV profile!

NeuroEV analysis for better health monitoring

NeuroEVs are small vesicles that are released from brain cells upon impact such as activation or damage. Studies show that changes in NeuroEV levels can be seen in various health conditions, such as fatigue, depression and long-term infections [1-5].

FBMLab - your partner for personal health monitoring

With FBMLab, you as a private individual can easily monitor your NeuroEV levels. We offer blood sampling and analysis of NeuroEVs, giving you a personalized and unique biomarker profile. By following your profile over time (recommended every 3/4 months depending on outcome) you get a more detailed picture of your NeuroEV profile. 

​

Simple sampling and quick results

The analysis takes place after a customary blood sampling. After the analysis, you will receive a written answer and statement about your NeuroEV levels within 1 week.

Medical assessment if necessary

If your levels are high, we recommend you to our partner NEM Health (Nordic Executive Medicine) for further medical assessment. You will find contact details in your final report from FBMLab. 

Important to know

The NeuroEV analysis is a supplement to your health check and should not be used for self-diagnosis. A more representative assessment of your condition is achieved by following the values over time. 

​

Invest in your health - discover your NeuroEV profile with FBMLab today!

​

1. Leakage of astrocyte-derived extracellular vesicles in stress-induced exhaustion disorder: a cross-sectional study. Sci Rep. 2021;11(1):2009.

2. Isoforms of soluble vascular endothelial growth factor in stress-related mental disorders: a cross-sectional study. Sci Rep. 2021;11(1):16693.

3. Increased astrocytes-derived biomarkers following COVID-19 normalize within one year. 2023, manuscript in prep

4. Brain-Derived Microparticles in Patients with Severe Isolated TBI. Brain injury, 31(13-14), 1856–1862.

5. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report. Journal of medical case reports, 2019, 13(1), 27.